Literature DB >> 3132370

Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study.

K Machka1, I Braveny, H Dabernat, K Dornbusch, E Van Dyck, F H Kayser, B Van Klingeren, H Mittermayer, E Perea, M Powell.   

Abstract

The first European survey of the prevalence of antibiotic resistance in Haemophilus influenzae was conducted between February and October 1986. Eighty laboratories in nine countries participated (Austria, Belgium, France, FRG, The Netherlands, Spain, Sweden, Switzerland and the UK). A total of 1,961 clinical isolates was examined for type b encapsulation, beta-lactamase production and susceptibility to ampicillin, chloramphenicol, cefaclor, erythromycin and tetracycline, using a unique microdilution method. The proportion of isolates resistant to these antibiotics varied considerably between individual countries. The highest prevalence of ampicillin resistance was found in Spain (30.6%), and the lowest in the FRG (1.6%), with a mean value of 10% for all countries. Chloramphenicol resistance was highest in Spain (24.9%) and Belgium (10.9%) and lowest in The Netherlands (0.6%) and Austria (0.5%), with a mean value of 4.7%. Resistance to erythromycin ranged from 27% of the isolates in The Netherlands to 1.1% in Austria. For tetracycline, values ranged from 1.5% in the UK to 17.8% in Belgium and 25.4% in Spain. The lowest mean prevalence of resistance was observed for cefaclor (breakpoint 8 mg/l): 5% or less in all countries. These inter-country differences could only partially be explained by variations in the proportion of type b strains, the source of the isolates and the mode of collection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132370     DOI: 10.1007/bf01962165

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae. Report of a study group on bacterial resistance.

Authors:  A J Howard; C J Hince; J D Williams
Journal:  Br Med J       Date:  1978-06-24

2.  Resistance of clinical isolates of Haemophilus influenzae in United Kingdom 1986.

Authors:  M Powell; C Koutsia-Carouzou; D Voutsinas; A Seymour; J D Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-18

3.  Meningitis due to chloramphenicol-resistant Haemophilus influenzae type b.

Authors:  A L Kinmonth; C N Storrs; R G Mitchell
Journal:  Br Med J       Date:  1978-03-18

4.  Ampicillin-resistant Haemophilus influenzae type B infection.

Authors:  M O Tomeh; S E Starr; J E McGowan; P M Terry; A J Nahmias
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

5.  Ampicillin and chloramphenicol resistance in systemic Haemophilus influenzae disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1984-01-27       Impact factor: 17.586

6.  Antibiotic susceptibility pattern and capsular types of Haemophilus influenzae recovered from clinical specimens in northern Norway.

Authors:  K Melby; T Leinslie; N Hagen; L H Vorland
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1983-12

7.  [Prevalence of antibiotic resistance of Haemophilus influenzae isolated in France: a year of activities of the network of surveillance for H. influenzae infections].

Authors:  H Dabernat; C Delmas; M B Lareng
Journal:  Pathol Biol (Paris)       Date:  1986-05

8.  Increasing ampicillin-resistance rates in Hemophilus influenzae meningitis.

Authors:  G R Istre; J S Conner; M P Glode; R S Hopkins
Journal:  Am J Dis Child       Date:  1984-04

9.  Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.

Authors:  G V Doern; J H Jorgensen; C Thornsberry; D A Preston
Journal:  Diagn Microbiol Infect Dis       Date:  1986-02       Impact factor: 2.803

10.  [Haemophilus influenzae isolated in Switzerland: antibiotic sensitivity and biotyping].

Authors:  B Borer-Bigliardi; J C Piffaretti
Journal:  Schweiz Med Wochenschr       Date:  1984-12-22
View more
  25 in total

1.  In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.

Authors:  J D Williams; M Powell; Y S Fah; A Seymour; M Yuan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

2.  Circulation in Italy of beta-lactamase-producing strains within the major groups of bacterial pathogens.

Authors:  P E Varaldo; G Nicoletti; G C Schito; A Maida; B Facinelli; S Stefani; G Gianrossi; E Muresu
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

3.  The Second European Collaborative Study on the frequency of antimicrobial resistance in Haemophilus influenzae.

Authors:  F H Kayser; G Morenzoni; P Santanam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

4.  Penetration of ampicillin and sulbactam in the lower airways during respiratory infections.

Authors:  Y J Valcke; M T Rosseel; R A Pauwels; M G Bogaert; M E Van der Straeten
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  In vitro activity of new antibiotics against Haemophilus influenzae.

Authors:  K Machka; H Balg; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

6.  Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999.

Authors:  F Marco; J García-de-Lomas; C García-Rey; E Bouza; L Aguilar; C Fernández-Mazarrasa
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

7.  Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease.

Authors:  W G Boersma; S M Puister; R van Altena; H G de Vries-Hospers; M Molinari; G H Koëter
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

Review 8.  Antibiotic resistance in Haemophilus influenzae: mechanisms, clinical importance and consequences for therapy.

Authors:  R de Groot; G Dzoljic-Danilovic; B van Klingeren; W H Goessens; H J Neyens
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

Review 9.  Cefetamet pivoxil clinical pharmacokinetics.

Authors:  R A Blouin; K Stoeckel
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

10.  A comparative study of clarithromycin and amoxycillin suspensions in the treatment of pediatric patients with acute otitis media.

Authors:  S J Coles; M B Addlestone; M K Kamdar; J L Macklin
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.